The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients

References

• Kamisawa T, Wood LD, Itoi T, et al. Pancreatic cancer. Lancet. 2016;388(10039):73–85.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Sohal DPS, Kennedy EB, Khorana A, et al. Metastatic pancreatic cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(24):2545–2556.
   PubMed Web of Science ®Google Scholar
• Dong X, Ma Y, Zhao X, et al. Spatial heterogeneity in epithelial to mesenchymal transition properties of circulating tumor cells associated with distant recurrence in pancreatic cancer patients. Ann Transl Med. 2020;8(11):676.
   PubMed Web of Science ®Google Scholar
• Piatek M, Kusnierz K, Bienkowski M, et al. Primarily resectable pancreatic adenocarcinoma - to operate or to refer the patient to an oncologist? Crit Rev Oncol Hematol. 2019;135:95–102.
   PubMed Web of Science ®Google Scholar
• Ren X, Zhou C, Lu Y, et al. Single-cell RNA-seq reveals invasive trajectory and determines cancer stem cell-related prognostic genes in pancreatic cancer. Bioengineered. 2021;12(1):5056–5068.
   PubMed Web of Science ®Google Scholar
• Groot VP, Rezaee N, Wu W, et al. Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2018;267(5):936–945.
   PubMed Web of Science ®Google Scholar
• Labori KJ, Katz MH, Tzeng CW, et al. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study. Acta Oncol. 2016;55(3):265–277.
   PubMed Web of Science ®Google Scholar
• Becker AE, Hernandez YG, Frucht H, et al. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol. 2014;20(32):11182–11198.
   PubMed Web of Science ®Google Scholar
• Ferrone CR, Finkelstein DM, Thayer SP, et al. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol. 2006;24(18):2897–2902.
   PubMed Web of Science ®Google Scholar
• Masuda T, Hayashi N, Iguchi T, et al. Clinical and biological significance of circulating tumor cells in cancer. Mol Oncol. 2016;10(3):408–417.
   PubMed Web of Science ®Google Scholar
• Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. 2013;339(6119):580–584.
   PubMed Web of Science ®Google Scholar
• Micalizzi DS, Haber DA, M S. Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells. Mol Oncol. 2017;11(7):770–780.
   PubMed Web of Science ®Google Scholar
• Pastushenko I, Brisebarre A, Sifrim A, et al. Identification of the tumour transition states occurring during EMT. Nature. 2018;556(7702):463–468.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu S, Chen L, et al. MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma. Bioengineered. 2021;12(1):2263–2273.
   PubMed Web of Science ®Google Scholar
• Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112(12):1776–1784.
   PubMed Web of Science ®Google Scholar
• Wei T, Zhang X, Zhang Q, et al. Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer. Cancer Lett. 2019;452:237–243.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Ofuji K, Hiramatsu K, et al. Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma. Cancer Med. 2021;10(7):2300–2309.
   PubMed Web of Science ®Google Scholar
• Huang C, Lin X, He J, et al. Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: a meta-analysis. Gynecol Oncol. 2021;161(2):613–620.
   PubMed Web of Science ®Google Scholar
• Ujiie D, Matsumoto T, Endo E, et al. Circulating tumor cells after neoadjuvant chemotherapy are related with recurrence in esophageal squamous cell carcinoma. Esophagus. 2021;18(3):566–573.
   PubMed Web of Science ®Google Scholar
• Martini V, Timme-Bronsert S, Fichtner-Feigl S, et al. Circulating tumor cells in pancreatic cancer: current perspectives. Cancers (Basel). 2019;11(11):1659.
   PubMed Web of Science ®Google Scholar
• Kulemann B, Pitman MB, Liss AS, et al. Circulating tumor cells found in patients with localized and advanced pancreatic cancer. Pancreas. 2015;44(4):547–550.
   PubMed Web of Science ®Google Scholar
• Court CM, Ankeny JS, Sho S, et al. Circulating tumor cells predict occult metastatic disease and prognosis in pancreatic cancer. Ann Surg Oncol. 2018;25(4):1000–1008.
   PubMed Web of Science ®Google Scholar
• Han L, Chen W, Zhao Q. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. Tumour Biol. 2014;35(3):2473–2480.
   PubMedGoogle Scholar
• Braun DA, Street K, Burke KP, et al. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. Cancer Cell. 2021;39(5):632–648.e8.
   PubMed Web of Science ®Google Scholar
• Peters FS, Strefford JC, Eldering E, et al. T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective. Haematologica. 2021;106(5):1234–1243.
   PubMed Web of Science ®Google Scholar
• Hung MH, Lee JS, Ma C, et al. Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma. Nat Commun. 2021;12(1):1455.
   PubMed Web of Science ®Google Scholar
• Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest. 2007;117(5):1119–1127.
   PubMed Web of Science ®Google Scholar
• Sekiya T, Kagawa S, Masaki K, et al. Regulation of peripheral Th/Treg differentiation and suppression of airway inflammation by Nr4a transcription factors. iScience. 2021;24(3):102166.
   PubMed Web of Science ®Google Scholar
• Xydia M, Rahbari R, Ruggiero E, et al. Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients. Nat Commun. 2021;12(1):1119.
   PubMed Web of Science ®Google Scholar
• Wang ZL, Zhang P, Li HC, et al. Dynamic changes of different phenotypic and genetic circulating tumor cells as a biomarker for evaluating the prognosis of RCC. Cancer Biol Ther. 2019;20(4):505–512.
   PubMed Web of Science ®Google Scholar
• Mousset CM, Hobo W, Woestenenk R, et al. Comprehensive phenotyping of T cells using flow cytometry. Cytometry A. 2019;95(6):647–654.
   PubMedGoogle Scholar
• Platchek M, Lu Q, Tran H, et al. Comparative analysis of multiple immunoassays for cytokine profiling in drug discovery. SLAS Discov. 2020;25(10):1197–1213.
   PubMed Web of Science ®Google Scholar
• Moon DH, Lindsay DP, Hong S, et al. Clinical indications for, and the future of, circulating tumor cells. Adv Drug Deliv Rev. 2018;125:143–150.
   PubMed Web of Science ®Google Scholar
• Scher HI, Armstrong AJ, Schonhoft JD, et al. Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer. Eur J Cancer. 2021;150:83–94.
   PubMed Web of Science ®Google Scholar
• Liu X, Wang C, Zhang L, et al. Prognostic and diagnostic values of circulating tumor cells and tumor markers for lung cancer. Clin Lab. 2021;67(4). DOI:10.7754/Clin.Lab.2020.200654.
   Web of Science ®Google Scholar
• White MG, Lee A, Vicente D, et al. Measurement of portal vein blood circulating tumor cells is safe and may correlate with outcomes in resected pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2021;28(8):4615–4622.
   PubMed Web of Science ®Google Scholar
• Zhu L, Kan KJ, Grun JL, et al. GAS2L1 is a potential biomarker of circulating tumor cells in pancreatic cancer. Cancers (Basel). 2020;12(12):3774.
   PubMed Web of Science ®Google Scholar
• Iovanna J. Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer. Transl Oncol. 2021;14(1):100965.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu Y, Zhang L, et al. Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer. J Cancer Res Clin Oncol. 2019;145(12):2911–2920.
   PubMed Web of Science ®Google Scholar
• S A, B I, B Z, et al. EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression. Oncotarget. 2017;8(30):49329–49337.
   PubMedGoogle Scholar
• Tt L, L H, Fp L, et al. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: relevance to therapy response. World J Gastroenterol. 2015;21(47):13259–13267.
   PubMed Web of Science ®Google Scholar
• Hyun K-A, Koo G-B, H H, et al. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer. Oncotarget. 2016;7(17):24677–24687.
   PubMedGoogle Scholar
• Hall CS, Karhade MG, Bowman Bauldry JB, et al. Prognostic value of circulating tumor cells identified before surgical resection in nonmetastatic breast cancer patients. J Am Coll Surg. 2016;223(1):20–29.
   PubMed Web of Science ®Google Scholar
• Schrijver B, Assmann J, van Gammeren AJ, et al. Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome. Eur Cytokine Netw. 2020;31(4):154–167.
   PubMed Web of Science ®Google Scholar
• Wiedemann A, Lettau M, Wirries I, et al. Human IgA-expressing bone marrow plasma cells characteristically upregulate programmed cell death protein-1 upon B cell receptor stimulation. Front Immunol. 2020;11:628923.
   PubMed Web of Science ®Google Scholar
• Gamah M, Alahdal M, Zhang Y, et al. High-altitude hypoxia exacerbates dextran sulfate sodium (DSS)-induced colitis by upregulating Th1 and Th17 lymphocytes. Bioengineered. 2021;12(1):7985–7994.
   PubMed Web of Science ®Google Scholar
• Liao R, Ma QZ, Zhou CY, et al. Identification of biomarkers related to Tumor-Infiltrating Lymphocytes (TILs) infiltration with gene co-expression network in colorectal cancer. Bioengineered. 2021;12(1):1676–1688.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Heimes AS. Immunomodulating therapies in breast cancer-from prognosis to clinical practice. Cancers (Basel). 2021;13(19):4883.
   PubMed Web of Science ®Google Scholar
• Zheng L, Qin S, Si W, et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 2021;374(6574):abe6474.
   PubMed Web of Science ®Google Scholar